Article Navigation
- < Previous
- Next >
Journal Article
Get access
, Hussain Muhammad Department of Management and Business Administration, “G. d’Annunzio” University of Chieti-Pescara , Viale Pindaro, n. 42, Pescara 65127, Italy *Main author for correspondence. Search for other works by this author on: Oxford Academic Stefania Migliori Department of Management and Business Administration, “G. d’Annunzio” University of Chieti-Pescara , Viale Pindaro, n. 42, Pescara 65127, Italy Search for other works by this author on: Oxford Academic Sana Mohsni Sprott School of Business, Carleton University , 7023 Nicol Building, 1125 Colonel by Drive, Ottawa, ON K1S 5B6, Canada Search for other works by this author on: Oxford Academic
Industrial and Corporate Change, Volume 31, Issue 3, June 2022, Pages 628–653, https://doi.org/10.1093/icc/dtab056
Published:
09 September 2021
Article history
Received:
09 January 2021
Revision received:
03 August 2021
Editorial decision:
17 August 2021
Accepted:
28 August 2021
Corrected and typeset:
09 September 2021
Published:
09 September 2021
- Views
- Article contents
- Figures & tables
- Video
- Audio
- Supplementary Data
-
Cite
Cite
Hussain Muhammad, Stefania Migliori, Sana Mohsni, Corporate governance and R&D investment: the role of debt financing, Industrial and Corporate Change, Volume 31, Issue 3, June 2022, Pages 628–653, https://doi.org/10.1093/icc/dtab056
Close
Search
Close
Search
Advanced Search
Search Menu
Abstract
This paper examines the role of debt financing in the relationship between corporate governance and research and development (R&D) investment using a sample of publicly traded U.S. pharmaceutical firms from 2009 to 2018. The results show a positive and significant association between corporate governance mechanisms (such as board size, board independence, board gender diversity, and ownership concentration) and R&D investment and a negative and significant association between debt financing and R&D investment. In addition, we show that debt financing plays a moderating role and a partial mediating role in the relationship between corporate governance mechanisms and R&D investment. Specifically, debt financing attenuates the negative effect of board size on R&D investment and accentuates the positive effect of ownership concentration on R&D investment. Our study helps to shed light on a close and complex relationship existing between the firm’s choices of corporate governance, debt financing, and R&D investments, which the previous literature has so far examined in a partial and fragmented way. To ensure effective R&D investment, firms need to consider the effect of debt financing on corporate governance decisions.
© The Author(s) 2021. Published by Oxford University Press in association with Oxford University Press and the Industrial and Corporate Change Association. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
JEL
G30 - General G31 - Capital Budgeting; Fixed Investment and Inventory Studies; Capacity G32 - Financing Policy; Financial Risk and Risk Management; Capital and Ownership Structure; Value of Firms; Goodwill L90 - General O30 - General
Issue Section:
Original Article
You do not currently have access to this article.
Download all slides
Sign in
Get help with access
Personal account
- Sign in with email/username & password
- Get email alerts
- Save searches
- Purchase content
- Activate your purchase/trial code
Sign in Register
Institutional access
- Sign in through your institution
- Sign in with a library card Sign in with username/password Recommend to your librarian
Institutional account management
Sign in as administrator
Get help with access
Institutional access
Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:
IP based access
Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.
Sign in through your institution
Choose this option to get remote access when outside your institution. Shibboleth/Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.
- Click Sign in through your institution.
- Select your institution from the list provided, which will take you to your institution's website to sign in.
- When on the institution site, please use the credentials provided by your institution. Do not use an Oxford Academic personal account.
- Following successful sign in, you will be returned to Oxford Academic.
If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.
Sign in with a library card
Enter your library card number to sign in. If you cannot sign in, please contact your librarian.
Society Members
Society member access to a journal is achieved in one of the following ways:
Sign in through society site
Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:
- Click Sign in through society site.
- When on the society site, please use the credentials provided by that society. Do not use an Oxford Academic personal account.
- Following successful sign in, you will be returned to Oxford Academic.
If you do not have a society account or have forgotten your username or password, please contact your society.
Sign in using a personal account
Some societies use Oxford Academic personal accounts to provide access to their members. See below.
Personal account
A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.
Some societies use Oxford Academic personal accounts to provide access to their members.
Viewing your signed in accounts
Click the account icon in the top right to:
- View your signed in personal account and access account management features.
- View the institutional accounts that are providing access.
Signed in but can't access content
Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.
Institutional account management
For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.
Purchase
Subscription prices and ordering for this journal
Purchasing options for books and journals across Oxford Academic
Short-term Access
To purchase short-term access, please sign in to your personal account above.
Don't already have a personal account? Register
Corporate governance and R&D investment: the role of debt financing - 24 Hours access
EUR €38.00
GBP £33.00
USD $41.00
Advertisem*nt
Citations
Views
711
Altmetric
More metrics information
Metrics
Total Views 711
446 Pageviews
265 PDF Downloads
Since 9/1/2021
Month: | Total Views: |
---|---|
September 2021 | 23 |
October 2021 | 14 |
November 2021 | 19 |
December 2021 | 8 |
January 2022 | 11 |
February 2022 | 9 |
March 2022 | 28 |
April 2022 | 23 |
May 2022 | 32 |
June 2022 | 70 |
July 2022 | 58 |
August 2022 | 21 |
September 2022 | 40 |
October 2022 | 42 |
November 2022 | 36 |
December 2022 | 17 |
January 2023 | 10 |
February 2023 | 20 |
March 2023 | 27 |
April 2023 | 27 |
May 2023 | 20 |
June 2023 | 16 |
July 2023 | 19 |
August 2023 | 25 |
September 2023 | 5 |
October 2023 | 12 |
November 2023 | 27 |
December 2023 | 19 |
January 2024 | 33 |
Altmetrics
Email alerts
Article activity alert
Advance article alerts
New issue alert
JEL classification alert
Receive exclusive offers and updates from Oxford Academic
Citing articles via
Google Scholar
-
Latest
-
Most Read
-
Most Cited
More from Oxford Academic
Business and Management
Economic Development and Growth
Economics
Innovation
Social Sciences
Technological Change; Research and Development
Books
Journals
Advertisem*nt
I am an expert in corporate governance, financial management, and research and development (R&D) investment within the pharmaceutical industry. My expertise spans both theoretical understanding and practical application in these domains. Allow me to provide evidence of my knowledge.
Firstly, I possess a comprehensive understanding of corporate governance mechanisms and their impact on firm behavior. Corporate governance encompasses a wide array of practices, including board composition, ownership structure, and managerial incentives, all of which influence decision-making within organizations. I am well-versed in empirical research examining the effects of these governance mechanisms on various firm outcomes, including R&D investment.
Secondly, my expertise extends to financial management, particularly in the context of debt financing. Debt financing is a crucial aspect of corporate finance, influencing firms' capital structure decisions and strategic choices. I am knowledgeable about the trade-offs involved in using debt versus equity financing, as well as the implications of debt levels on firm performance and investment behavior.
Thirdly, I have a deep understanding of R&D investment dynamics, especially within the pharmaceutical sector. R&D investment is essential for innovation and competitiveness in industries characterized by rapid technological change, such as pharmaceuticals. I am familiar with the factors driving firms' decisions to allocate resources to R&D activities, as well as the impact of R&D investment on long-term firm performance and innovation outcomes.
Now, let's delve into the concepts mentioned in the provided article:
-
Corporate Governance: This refers to the system of rules, practices, and processes by which a company is directed and controlled. It includes mechanisms such as board size, board independence, board gender diversity, and ownership concentration. Effective corporate governance ensures that the interests of various stakeholders are balanced and aligned with the company's objectives.
-
Debt Financing: Debt financing involves raising capital by borrowing funds, typically through loans or issuing bonds, with the promise of repayment with interest. Debt financing affects a company's capital structure and financial risk profile. It is essential to understand how debt levels influence firm behavior and strategic decisions.
-
Research and Development (R&D) Investment: R&D investment refers to the allocation of resources towards activities aimed at innovation, product development, and technological advancement. In industries like pharmaceuticals, R&D investment is critical for sustaining competitiveness and driving future growth.
-
Pharmaceutical Industry: This sector focuses on the research, development, production, and marketing of drugs and medications. It is characterized by high levels of R&D expenditure, regulatory scrutiny, and competition among firms to bring new therapies to market.
The article explores the interplay between corporate governance, debt financing, and R&D investment in publicly traded U.S. pharmaceutical firms. It investigates how various corporate governance mechanisms influence R&D investment decisions and examines the moderating and mediating role of debt financing in this relationship. The findings provide insights into the complex dynamics shaping firms' strategic choices in an industry known for its innovation and reliance on R&D.